New Zealand has a limited range of ventures producing medicinal cannabis - but the most successful distributor doesn't even sell directly to Kiwis.

Medical marijuana company Puro has just signed a $16 million distribution deal in the UK, but co-founder Tim Aldridge says red tape is stopping the business from selling domestically.

Aldridge says there's no manufacturing or packaging companies that can take their product - and they need to ship that out to Australia.

LISTEN ABOVE

New Zealand has a limited range of ventures producing medicinal cannabis - but the most successful distributor doesn't even sell directly to Kiwis.
Medical marijuana company Puro has just signed a $16 million distribution deal in the UK, but co-founder Tim Aldridge says red tape is stopping the business from selling domestically.
Aldridge says there's no manufacturing or packaging companies that can take their product - and they need to ship that out to Australia.
LISTEN ABOVE

With a straight down the middle approach, Heather du Plessis-Allan Drive on Newstalk ZB delivers the very latest news and views to New Zealanders as they wrap up their day.

Heather du Plessis-Allan Drive

Tim Aldridge: Puro co-founder on the regulations impacting cannabis distribution in NZ

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/a22a15ef-dba4-4c4e-8de2-b3130086c051/transcript

Germany's AfD has come out on top in this weekend's state elections, with the party winning 43.8 percent of the vote.

This is the first time a far-right party has won control of a state since World War II.

UK correspondent Gavin Grey says these are only preliminary results, but this result is sending 'alarm bells' among the nation amid the ongoing Russia-Ukraine war. 

LISTEN ABOVE

Germany's AfD has come out on top in this weekend's state elections, with the party winning 43.8 percent of the vote.
This is the first time a far-right party has won control of a state since World War II.
UK correspondent Gavin Grey says these are only preliminary results, but this result is sending 'alarm bells' among the nation amid the ongoing Russia-Ukraine war.&nbsp;
LISTEN ABOVE

Gavin Grey: UK correspondent on Germany's AfD winning historic victory in state election

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/9d38feec-d6ae-42e3-82ca-b4be00888d88/transcript

The US and Iran have launched more tit-for-tat strikes over the weekend, resulting in oil prices going up - but what has it done for the markets?

Experts indicate the Asia-Pacific market is still going strong, with the index going up by 1.1 percent.

Harbour Asset Management Shane Solly explained further - and revealed why Korean chipmakers are helping things grow.

LISTEN ABOVE

The US and Iran have launched more tit-for-tat strikes over the weekend, resulting in oil prices going up - but what has it done for the markets?
Experts indicate the Asia-Pacific market is still going strong, with the index going up by 1.1 percent.
Harbour Asset Management Shane Solly explained further - and revealed why Korean chipmakers are helping things grow.
LISTEN ABOVE

Shane Solly: Harbour Asset Management expert on the Asia-Pacific market reactions to the Middle East conflict

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/3518532d-af65-4502-a494-b4be0085d7b8/transcript

BusinessNZ's calling for a funding reset on medicines, with a new report highlighting the long-term benefits of investing more into healthcare.

The report shows every dollar invested into medicine returns $1.93 to the economy. 

BusinessNZ CEO Katherine Rich explained that there's long-term benefits into investing more, including boosting productivity and improving the quality of life for New Zealand families. 

"It takes up to six years to get a new drug through - and these are drugs that are available freely not just in Australia, but around the globe." 

LISTEN ABOVE

BusinessNZ's calling for a funding reset on medicines, with a new report highlighting the long-term benefits of investing more into healthcare.
The report shows every dollar invested into medicine returns $1.93 to the economy.&nbsp;
BusinessNZ CEO Katherine Rich explained that there's long-term benefits into investing more, including boosting productivity and improving the quality of life for New Zealand families.&nbsp;
"It takes up to six years to get a new drug through - and these are drugs that are available freely not just in Australia, but around the globe."&nbsp;
LISTEN ABOVE

Katherine Rich: BusinessNZ Chief Executive on the new report warning NZ to spend more on medicines

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/09d6d0dd-614c-42b7-89bd-b4be0081b7c2/transcript

Tim Aldridge: Puro co-founder on the regulations impacting cannabis distribution in NZ

In 1 playlist(s)

Heather du Plessis-Allan Drive

Social links

Follow podcast

Recent clips